Chang-Do Gong

Chang-Do Gong

Chang-Do Gong is a partner in Dewey & LeBoeuf's Mergers & Acquisitions Group. He has represented acquirors, targets, boards of directors, special committees and investment banks in several complex domestic and cross-border, negotiated and unsolicited, and public and private transactions, including The Walt Disney Company, Eli Lilly and Company, Sony Corporation of America, Sumitomo Corporation, MedImmune, Inc., Zimmer Holdings, Inc., Omnicare, Inc., Actavis Group h.f., Illumina, Inc., Credit Suisse Securities (USA) LLC, The Blackstone Group, UBS Securities LLC, Citigroup Global Markets Inc., Merrill Lynch & Co. and Bank of America Securities LLC.

Mr. Gong has participated in a number of significant transactions, including Zimmer Holdings' cross-border unsolicited acquisition of Centerpulse; Sony Corporation of America in its acquisition of Metro-Goldwyn-Mayer with a consortium of private equity firms; Omnicare's unsolicited acquisitions of NeighborCare and NCS Healthcare; Actavis Group's acquisition of Alpharma's human generics business; Illumina's acquisition of Solexa; GS Capital Partners' acquisition of USI Holdings; Cegedim's acquisition of Dendrite International; Genstar Capital's acquisition of PRA International; and AstraZeneca's acquisition of MedImmune.